Met Life Investment Management, LLC Standard Biotools Inc. Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 143,325 shares of LAB stock, worth $226,453. This represents 0.0% of its overall portfolio holdings.
Number of Shares
143,325
Previous 76,915
86.34%
Holding current value
$226,453
Previous $136,000
102.94%
% of portfolio
0.0%
Previous 0.0%
Shares
39 transactions
Others Institutions Holding LAB
# of Institutions
144Shares Held
279MCall Options Held
27.2KPut Options Held
34.1K-
Casdin Capital, LLC New York, NY71.3MShares$113 Million10.68% of portfolio
-
Viking Global Investors LP58.7MShares$92.7 Million0.44% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$34.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.3MShares$27.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY15.2MShares$24.1 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $124M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...